Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.12347
Abstract: Key Points Question Is cytoreductive nephrectomy associated with improved overall survival for patients with metastatic clear cell renal cell carcinoma? Findings In this cohort study of 12 766 patients, receipt of a cytoreductive nephrectomy was not… read more here.
Keywords: cell; survival; cytoreductive nephrectomy; metastatic clear ... See more keywords
Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34174
Abstract: This study was aimed at assessing the associations of sarcopenia, muscle density, adiposity, and inflammation with overall survival (OS) after cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma. read more here.
Keywords: cell carcinoma; renal cell; metastatic renal; cytoreductive nephrectomy ... See more keywords
A qualitative framework of non-selection factors for cytoreductive nephrectomy
Sign Up to like & getrecommendations! Published in 2021 at "World Journal of Urology"
DOI: 10.1007/s00345-021-03650-4
Abstract: Cytoreductive nephrectomy (CN) benefits a subset of patients with metastatic renal cell carcinoma (mRCC), however proper patient selection remains complex and controversial. We aim to characterize urologists’ reasons for not undertaking a CN at a… read more here.
Keywords: framework; selection; non selection; framework non ... See more keywords
Individualised Indications for Cytoreductive Nephrectomy: Which Criteria Define the Optimal Candidates?
Sign Up to like & getrecommendations! Published in 2019 at "European urology oncology"
DOI: 10.1016/j.euo.2019.04.007
Abstract: CONTEXT The current role of cytoreductive nephrectomy (CN) is controversial. OBJECTIVE Review of the available evidence about criteria defining CN optimal candidates. EVIDENCE ACQUISITION Collaborative critical narrative review of the literature focusing on CN oncological… read more here.
Keywords: optimal candidates; risk; systemic therapy; presurgical systemic ... See more keywords
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma.
Sign Up to like & getrecommendations! Published in 2020 at "European urology oncology"
DOI: 10.1016/j.euo.2020.04.006
Abstract: BACKGROUND Cytoreductive nephrectomy (CN) plays an important role in the treatment of a subgroup of metastatic renal cell carcinoma (mRCC) patients. OBJECTIVE We aimed to evaluate morbidity associated with this procedure and identify potential predictors… read more here.
Keywords: renal cell; analysis; cell carcinoma; registry metastatic ... See more keywords
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC).
Sign Up to like & getrecommendations! Published in 2020 at "European urology oncology"
DOI: 10.1016/j.euo.2020.12.010
Abstract: BACKGROUND Selection of patients for upfront cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC) has to be improved. OBJECTIVE To evaluate a new scoring system for the prediction of overall mortality (OM) in mRCC… read more here.
Keywords: renal cell; risk; remarcc; metastatic renal ... See more keywords
Position of cytoreductive nephrectomy in the setting of metastatic renal cell carcinoma patients: does the CARMENA trial lead to a paradigm shift?
Sign Up to like & getrecommendations! Published in 2018 at "Bulletin du cancer"
DOI: 10.1016/s0007-4551(18)30377-1
Abstract: Introduction > The role of cytoreductive nephrectomy (CN) in combination with targeted therapy has been debated after the results of the CARMENA trial. We decided to reassess the available evidence on the setting of CN… read more here.
Keywords: renal cell; trial; metastatic renal; cytoreductive nephrectomy ... See more keywords
The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the targeted therapy and immunological therapy era: a systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2023 at "International journal of surgery"
DOI: 10.1097/js9.0000000000000314
Abstract: BACKGROUND The role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC) remains controversial. In addition, several unanswered questions regarding the use of CN remain: Can CN provide survival benefits for patients with mRCC?… read more here.
Keywords: cytoreductive nephrectomy; role cytoreductive; therapy; patients mrcc ... See more keywords
The evolving role of cytoreductive nephrectomy.
Sign Up to like & getrecommendations! Published in 2019 at "Current Opinion in Urology"
DOI: 10.1097/mou.0000000000000653
Abstract: DOI:10.1097/MOU.0000000000000653 Over 65 000 new cases of kidney cancer are diagnosed in the United States annually, with nearly 15 000 attributable deaths each year. On the contrary, 30–40% of patients already harbor metastatic disease at… read more here.
Keywords: role; evolving role; mrcc; year ... See more keywords
The role of cytoreductive nephrectomy in the immuno-oncological therapy era
Sign Up to like & getrecommendations! Published in 2023 at "Current Opinion in Urology"
DOI: 10.1097/mou.0000000000001077
Abstract: Purpose of review Cytoreductive nephrectomy has had a variable role in the management of metastatic renal cell carcinoma (RCC) through the different systemic therapy eras. Initially felt to be beneficial with interferon, the utility of… read more here.
Keywords: cytoreductive nephrectomy; role cytoreductive; therapy; nephrectomy ... See more keywords
Abstract 6473: Outcomes of advanced renal cell carcinoma with sarcomatoid features post-cytoreductive nephrectomy in clear cell and non-clear cell disease
Sign Up to like & getrecommendations! Published in 2020 at "Endocrinology"
DOI: 10.1158/1538-7445.am2020-6473
Abstract: Background: Cytoreductive nephrectomy in the setting of treatment of advanced renal cell carcinoma with sarcomatoid features (sRCC) has been highly contested in terms of added benefit for survival. Patients with sRCC are known to have… read more here.
Keywords: cytoreductive nephrectomy; cell; clear cell; sarcomatoid features ... See more keywords